Product Information
HUMULIN N 100 UNIT/ML VIAL is a brand product labeled by Eli Lilly and Company, priced at $4.2674 per ML under NDC 00002831501. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002831501
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA018781On Market Since
6/27/1983
Pharmacological Classes
Price Statistics
The NADAC for HUMULIN N 100 UNIT/ML VIAL has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2674 per ML |
|---|---|
| All-time high | $14.6101 (Nov 14, 2018) |
| All-time low | $4.2660 (Jun 17, 2026) |
| 52-week high | $4.2744 |
| 52-week low | $4.2660 |
| Median price | $14.2651 |
| Average price | $11.4619 |
| Largest weekly change | -70.0% (Jan 10, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Insulin human market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HUMULIN N 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HUMULIN N 100 UNIT/ML VIAL, manufactured by Eli Lilly and Company, is $4.2674 per ML (NDC 00002831501), effective Sep 30, 2026.
How has the price of HUMULIN N 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for HUMULIN N 100 UNIT/ML VIAL has declined 47.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HUMULIN N 100 UNIT/ML VIAL?
Since Nov 28, 2013, the NADAC for HUMULIN N 100 UNIT/ML VIAL has ranged from a low of $4.2660 (Jun 17, 2026) to a high of $14.6101 (Nov 14, 2018), with a median of $14.2651 per ML.
Are there cheaper alternatives to HUMULIN N 100 UNIT/ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HUMULIN 70-30 VIAL, is $4.2564 per ML — about 0% below HUMULIN N 100 UNIT/ML VIAL.
Who manufactures HUMULIN N 100 UNIT/ML VIAL?
HUMULIN N 100 UNIT/ML VIAL (NDC 00002831501) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.